-
1
-
-
0025304539
-
Rheumatoid arthritis. Pathophysiology and implications for therapy
-
Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
-
(1990)
N Engl J Med
, vol.322
, pp. 1277-1289
-
-
Harris Jr., E.D.1
-
2
-
-
0032981611
-
-
Van der Heijde DM. How to read radiographs according to the Sharp/van der Heijde method [corrected and republished in J Rheumatol 2000 Jan;27:261-3]. J Rheumatol 1999;26:743-5.
-
Van der Heijde DM. How to read radiographs according to the Sharp/van der Heijde method [corrected and republished in J Rheumatol 2000 Jan;27:261-3]. J Rheumatol 1999;26:743-5.
-
-
-
-
3
-
-
0033501902
-
Long-term course and outcome of functional capacity in rheumatoid arthritis: The effect of disease activity and radiologic damage over time
-
Drossaers-Bakker KW, de Buck M, van Zeben D, Zwinderman AH, Breedveld FC, Hazes JM. Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum 1999;42:1854-60.
-
(1999)
Arthritis Rheum
, vol.42
, pp. 1854-1860
-
-
Drossaers-Bakker, K.W.1
de Buck, M.2
van Zeben, D.3
Zwinderman, A.H.4
Breedveld, F.C.5
Hazes, J.M.6
-
4
-
-
0027238592
-
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
-
Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
-
(1993)
Arthritis Rheum
, vol.36
, pp. 729-740
-
-
Felson, D.T.1
Anderson, J.J.2
Boers, M.3
Bombardier, C.4
Chernoff, M.5
Fried, B.6
-
5
-
-
0031451998
-
Combination therapy in early rheumatoid arthritis: The COBRA study
-
In Dutch
-
Boers M, Verhoeven AC, van der Linden S. Combination therapy in early rheumatoid arthritis: the COBRA study. Ned Tijdschr Geneeskd 1997;141:2428-32. In Dutch.
-
(1997)
Ned Tijdschr Geneeskd
, vol.141
, pp. 2428-2432
-
-
Boers, M.1
Verhoeven, A.C.2
van der Linden, S.3
-
6
-
-
17244364098
-
Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study
-
Smolen JS, Han C, Bala M, Maini RN, Kalden JR, van der Heijde D, et al. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study. Arthritis Rheum 2005;52:1020-30.
-
(2005)
Arthritis Rheum
, vol.52
, pp. 1020-1030
-
-
Smolen, J.S.1
Han, C.2
Bala, M.3
Maini, R.N.4
Kalden, J.R.5
van der Heijde, D.6
-
7
-
-
0031715621
-
Validation of rheumatoid arthritis improvement criteria that include simplified joint counts
-
Van Gestel AM, Haagsma CJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998;41:1845-50.
-
(1998)
Arthritis Rheum
, vol.41
, pp. 1845-1850
-
-
Van Gestel, A.M.1
Haagsma, C.J.2
van Riel, P.L.3
-
8
-
-
13444254086
-
Interleukin-18: A therapeutic target in rheumatoid arthritis?
-
McInnes IB, Liew FY, Gracie JA. Interleukin-18: a therapeutic target in rheumatoid arthritis? Arthritis Res Ther 2005;7:38-41.
-
(2005)
Arthritis Res Ther
, vol.7
, pp. 38-41
-
-
McInnes, I.B.1
Liew, F.Y.2
Gracie, J.A.3
-
9
-
-
0028807079
-
Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis
-
Van der Heide A, Remme CA, Hofman DM, Jacobs JW, Bijlsma JW. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum 1995;38:1466-74.
-
(1995)
Arthritis Rheum
, vol.38
, pp. 1466-1474
-
-
Van der Heide, A.1
Remme, C.A.2
Hofman, D.M.3
Jacobs, J.W.4
Bijlsma, J.W.5
-
10
-
-
0030070401
-
Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis
-
Eberhardt K, Fex E, Johnson U, Wollheim FA. Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis. Ann Rheum Dis 1996;55:34-9.
-
(1996)
Ann Rheum Dis
, vol.55
, pp. 34-39
-
-
Eberhardt, K.1
Fex, E.2
Johnson, U.3
Wollheim, F.A.4
-
11
-
-
0034833986
-
Predictors of radiographic joint damage in patients with early rheumatoid arthritis
-
Jansen LM, van der Horst-Bruinsma IE, van Schaardenburg D, Bezemer PD, Dijkmans BA. Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann Rheum Dis 2001;60:924-7.
-
(2001)
Ann Rheum Dis
, vol.60
, pp. 924-927
-
-
Jansen, L.M.1
van der Horst-Bruinsma, I.E.2
van Schaardenburg, D.3
Bezemer, P.D.4
Dijkmans, B.A.5
-
12
-
-
13244252643
-
Prognostic laboratory markers of joint damage in rheumatoid arthritis
-
Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D, Saxne T. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 2005;64:196-201.
-
(2005)
Ann Rheum Dis
, vol.64
, pp. 196-201
-
-
Lindqvist, E.1
Eberhardt, K.2
Bendtzen, K.3
Heinegard, D.4
Saxne, T.5
-
13
-
-
0001817366
-
Cell biology of cartilage degradation
-
Henderson B, Edwards JC, Pettipher ER, editors, London: Academic Press;
-
Poole A, Alini M, Hollander A. Cell biology of cartilage degradation. In: Henderson B, Edwards JC, Pettipher ER, editors. Mechanisms and models in rheumatoid arthritis. London: Academic Press; 1995. p. 163-204.
-
(1995)
Mechanisms and models in rheumatoid arthritis
, pp. 163-204
-
-
Poole, A.1
Alini, M.2
Hollander, A.3
-
14
-
-
0036822673
-
Can serum biomarker assays measure the progression of cartilage degeneration in osteoarthritis? [editorial]
-
Poole AR. Can serum biomarker assays measure the progression of cartilage degeneration in osteoarthritis? [editorial]. Arthritis Rheum 2002;46:2549-52.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 2549-2552
-
-
Poole, A.R.1
-
15
-
-
0028322114
-
Biological markers in rheumatoid arthritis
-
Poole AR, Dieppe P. Biological markers in rheumatoid arthritis. Semin Arthritis Rheum 1994;23 Suppl 2:17-31.
-
(1994)
Semin Arthritis Rheum
, vol.23
, Issue.SUPPL. 2
, pp. 17-31
-
-
Poole, A.R.1
Dieppe, P.2
-
16
-
-
0027588239
-
Joint fluid carboxy-terminal type II procollagen peptide as a marker of cartilage collagen biosynthesis
-
Shinmei M, Ito K, Matsuyama S, Yoshihara Y, Matsuzawa K. Joint fluid carboxy-terminal type II procollagen peptide as a marker of cartilage collagen biosynthesis. Osteoarthritis Cartilage 1993;1:121-8.
-
(1993)
Osteoarthritis Cartilage
, vol.1
, pp. 121-128
-
-
Shinmei, M.1
Ito, K.2
Matsuyama, S.3
Yoshihara, Y.4
Matsuzawa, K.5
-
17
-
-
0028934327
-
Cartilage and bone metabolism in rheumatoid arthritis: Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism
-
Mansson B, Carey D, Alini M, Ionescu M, Rosenberg LC, Poole AR, et al. Cartilage and bone metabolism in rheumatoid arthritis: differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest 1995;95:1071-7.
-
(1995)
J Clin Invest
, vol.95
, pp. 1071-1077
-
-
Mansson, B.1
Carey, D.2
Alini, M.3
Ionescu, M.4
Rosenberg, L.C.5
Poole, A.R.6
-
18
-
-
70350491339
-
Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: An evaluation from 1 to 4 years after diagnosis
-
Verstappen S, Poole A, Ionescu M, King L, Abrahamowicz M, Hofman D, et al. Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis. Arthritis Res Ther 2006;8:R31.
-
(2006)
Arthritis Res Ther
, vol.8
-
-
Verstappen, S.1
Poole, A.2
Ionescu, M.3
King, L.4
Abrahamowicz, M.5
Hofman, D.6
-
19
-
-
2342499811
-
Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis
-
Landewe R, Geusens P, Boers M, van der Heijde D, Lems W, te Koppele J, et al. Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis. Arthritis Rheum 2004;50:1390-9.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 1390-1399
-
-
Landewe, R.1
Geusens, P.2
Boers, M.3
van der Heijde, D.4
Lems, W.5
te Koppele, J.6
-
20
-
-
0242579596
-
Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: Relationship to mediators of systemic and local inflammation
-
Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, et al. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Arthritis Rheum 2003;48:3085-95.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 3085-3095
-
-
Fraser, A.1
Fearon, U.2
Billinghurst, R.C.3
Ionescu, M.4
Reece, R.5
Barwick, T.6
-
21
-
-
0024549792
-
Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in expiants of bovine articular cartilage cultured with interleukin 1
-
Dodge GR, Poole AR. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in expiants of bovine articular cartilage cultured with interleukin 1. J Clin Invest 1989;83:647-61.
-
(1989)
J Clin Invest
, vol.83
, pp. 647-661
-
-
Dodge, G.R.1
Poole, A.R.2
-
22
-
-
0028328915
-
Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay
-
Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, et al. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 1994;93:1722-32.
-
(1994)
J Clin Invest
, vol.93
, pp. 1722-1732
-
-
Hollander, A.P.1
Heathfield, T.F.2
Webber, C.3
Iwata, Y.4
Bourne, R.5
Rorabeck, C.6
-
23
-
-
0028839263
-
Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration
-
Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 1995;96:2859-69.
-
(1995)
J Clin Invest
, vol.96
, pp. 2859-2869
-
-
Hollander, A.P.1
Pidoux, I.2
Reiner, A.3
Rorabeck, C.4
Bourne, R.5
Poole, A.R.6
-
24
-
-
0030891983
-
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage
-
Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997;99:1534-45.
-
(1997)
J Clin Invest
, vol.99
, pp. 1534-1545
-
-
Billinghurst, R.C.1
Dahlberg, L.2
Ionescu, M.3
Reiner, A.4
Bourne, R.5
Rorabeck, C.6
-
25
-
-
0142029334
-
Mediators of inflammation, tissue destruction, and repair: D. Proteases and their inhibitors
-
Klippel JH, Crofford LJ, Stone JH, Weyand CM, editors, 12th ed. Atlanta: Arthritis Foundation;
-
Mort JS, Poole AR. Mediators of inflammation, tissue destruction, and repair: D. Proteases and their inhibitors. In: Klippel JH, Crofford LJ, Stone JH, Weyand CM, editors. Primer on the rheumatic diseases. 12th ed. Atlanta: Arthritis Foundation; 2001. p. 72-81.
-
(2001)
Primer on the rheumatic diseases
, pp. 72-81
-
-
Mort, J.S.1
Poole, A.R.2
-
26
-
-
10344223475
-
The assessment of cartilage degradation in vivo: Development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases
-
Poole A, Ionescu M, Fitzcharles MA, Billinghurst RC. The assessment of cartilage degradation in vivo: development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases. J Immunol Methods 2004;294:145-53.
-
(2004)
J Immunol Methods
, vol.294
, pp. 145-153
-
-
Poole, A.1
Ionescu, M.2
Fitzcharles, M.A.3
Billinghurst, R.C.4
-
27
-
-
0035154449
-
Early degradation of type IX and type II collagen with the onset of experimental inflammatory arthritis
-
Kojima T, Mwale F, Yasuda T, Girard C, Poole AR, Laverty S. Early degradation of type IX and type II collagen with the onset of experimental inflammatory arthritis. Arthritis Rheum 2001;44:120-7.
-
(2001)
Arthritis Rheum
, vol.44
, pp. 120-127
-
-
Kojima, T.1
Mwale, F.2
Yasuda, T.3
Girard, C.4
Poole, A.R.5
Laverty, S.6
-
28
-
-
0033575758
-
Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis
-
Song X, Zeng L, Jin W, Thompson J, Mizel DE, Lei K, et al. Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J Exp Med 1999;190:535-42.
-
(1999)
J Exp Med
, vol.190
, pp. 535-542
-
-
Song, X.1
Zeng, L.2
Jin, W.3
Thompson, J.4
Mizel, D.E.5
Lei, K.6
-
29
-
-
0028899665
-
Significance of the levels of carboxy terminal type II procollagen peptide, chondroitin sulfate isomers, tissue inhibitor of metalloproteinases, and metalloproteinases in osteoarthritis joint fluid
-
Shinmei M, Kobayashi T, Yoshihara Y, Samura A. Significance of the levels of carboxy terminal type II procollagen peptide, chondroitin sulfate isomers, tissue inhibitor of metalloproteinases, and metalloproteinases in osteoarthritis joint fluid. J Rheumatol Suppl 1995;43:78-81.
-
(1995)
J Rheumatol Suppl
, vol.43
, pp. 78-81
-
-
Shinmei, M.1
Kobayashi, T.2
Yoshihara, Y.3
Samura, A.4
-
30
-
-
10244234102
-
Procollagen II C-propeptide in joint fluid: Changes in concentration with age, time after knee injury, and osteoarthritis
-
Lohmander LS, Yoshihara Y, Roos H, Kobayashi T, Yamada H, Shinmei M. Procollagen II C-propeptide in joint fluid: changes in concentration with age, time after knee injury, and osteoarthritis. J Rheumatol 1996;23:1765-9.
-
(1996)
J Rheumatol
, vol.23
, pp. 1765-1769
-
-
Lohmander, L.S.1
Yoshihara, Y.2
Roos, H.3
Kobayashi, T.4
Yamada, H.5
Shinmei, M.6
-
31
-
-
0032535446
-
Evidence for altered synthesis of type II collagen in patients with osteoarthritis
-
Nelson F, Dahlberg L, Laverty S, Reiner A, Pidoux I, Ionescu M, et al. Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest 1998;102:2115-25.
-
(1998)
J Clin Invest
, vol.102
, pp. 2115-2125
-
-
Nelson, F.1
Dahlberg, L.2
Laverty, S.3
Reiner, A.4
Pidoux, I.5
Ionescu, M.6
-
32
-
-
1042301978
-
Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis
-
Matyas JR, Atley L, Ionescu M, Eyre DR, Poole AR. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis. Arthritis Rheum 2004;50:543-52.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 543-552
-
-
Matyas, J.R.1
Atley, L.2
Ionescu, M.3
Eyre, D.R.4
Poole, A.R.5
-
33
-
-
0023945481
-
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
-
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
-
(1988)
Arthritis Rheum
, vol.31
, pp. 315-324
-
-
Arnett, F.C.1
Edworthy, S.M.2
Bloch, D.A.3
McShane, D.J.4
Fries, J.F.5
Cooper, N.S.6
-
34
-
-
0027955027
-
Classification of clinical subsets in psoriatic arthritis
-
Veale D, Rogers S, FitzGerald O. Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 1994;33:133-8.
-
(1994)
Br J Rheumatol
, vol.33
, pp. 133-138
-
-
Veale, D.1
Rogers, S.2
FitzGerald, O.3
-
35
-
-
0028815803
-
Modified disease activity scores that include twenty-eight-joint counts: Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
-
Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
-
(1995)
Arthritis Rheum
, vol.38
, pp. 44-48
-
-
Prevoo, M.L.1
van 't Hof, M.A.2
Kuper, H.H.3
van Leeuwen, M.A.4
van de Putte, L.B.5
van Riel, P.L.6
-
36
-
-
33750331541
-
Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: Analysis of data from randomised, controlled trials of two tumour necrosis factor inhibitors
-
Fransen J, Antoni C, Mease PJ, Uter W, Kavanaugh A, Kalden JR, et al. Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised, controlled trials of two tumour necrosis factor inhibitors. Ann Rheum Dis 2006;65:1373-8.
-
(2006)
Ann Rheum Dis
, vol.65
, pp. 1373-1378
-
-
Fransen, J.1
Antoni, C.2
Mease, P.J.3
Uter, W.4
Kavanaugh, A.5
Kalden, J.R.6
-
38
-
-
0034104307
-
The links between joint damage and disability in rheumatoid arthritis
-
Scott DL, Pugner K, Kaarela K, Doyle DV, Woolf A, Holmes J, et al. The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford) 2000;39:122-32.
-
(2000)
Rheumatology (Oxford)
, vol.39
, pp. 122-132
-
-
Scott, D.L.1
Pugner, K.2
Kaarela, K.3
Doyle, D.V.4
Woolf, A.5
Holmes, J.6
-
39
-
-
13244272359
-
Deciding on progression of joint damage in paired films of individual patients: Smallest detectable difference or change
-
Bruynesteyn K, Boers M, Kostense P, van der Linden S, van der Heijde D. Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change. Ann Rheum Dis 2005;64:179-82.
-
(2005)
Ann Rheum Dis
, vol.64
, pp. 179-182
-
-
Bruynesteyn, K.1
Boers, M.2
Kostense, P.3
van der Linden, S.4
van der Heijde, D.5
-
40
-
-
33744744388
-
Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis
-
Mazzuca SA, Poole AR, Brandt KD, Katz BP, Lane KA, Lobanok T. Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis. J Rheumatol 2006;33:1147-51.
-
(2006)
J Rheumatol
, vol.33
, pp. 1147-1151
-
-
Mazzuca, S.A.1
Poole, A.R.2
Brandt, K.D.3
Katz, B.P.4
Lane, K.A.5
Lobanok, T.6
-
41
-
-
26444474599
-
Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis
-
Maksymowych WP, Poole AR, Hiebert L, Webb A, Ionescu M, Lobanok T, et al. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis. J Rheumatol 2005;32:1911-7.
-
(2005)
J Rheumatol
, vol.32
, pp. 1911-1917
-
-
Maksymowych, W.P.1
Poole, A.R.2
Hiebert, L.3
Webb, A.4
Ionescu, M.5
Lobanok, T.6
-
42
-
-
0037242710
-
Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis
-
Green MJ, Gough AK, Devlin J, Smith J, Astin P, Taylor D, et al. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology (Oxford) 2003;42:83-8.
-
(2003)
Rheumatology (Oxford)
, vol.42
, pp. 83-88
-
-
Green, M.J.1
Gough, A.K.2
Devlin, J.3
Smith, J.4
Astin, P.5
Taylor, D.6
-
43
-
-
0035306510
-
Uncoupling of inflammatory and destructive mechanisms in arthritis
-
Van den Berg WB. Uncoupling of inflammatory and destructive mechanisms in arthritis. Semin Arthritis Rheum 2001;30(5 Suppl 2):7-16.
-
(2001)
Semin Arthritis Rheum
, vol.30
, Issue.5 SUPPL. 2
, pp. 7-16
-
-
Van den Berg, W.B.1
|